About this trial
Epidemiology studies showed that the burden of cardiogenic shock (CS) persistently high, with increasing annual medical expenses and steady prevalence. In-hospital and one-year mortality reduce annually. Hence, there are increasing number of patients who survive to hospital discharge but they will face further challenges in the subacute stage after hospital discharge. However, there are still insufficient studies focusing on this issue. Establishment of a healthcare neatwork to help hospital survivors of CS return society safely is critical.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Age < 18 years。
Patient or family refuse follow-up.
Patient died within hospital stay.
Trial population
Hospital survivors of cardiogenic shock
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
mortality
any death
rehospitalization
any rehospitalization
Secondary outcomes
mortality
any death
rehospitalization
any rehospitalization
mortality
any death
rehospitalization
any rehospitalization
Other outcomes
Quality
KCCQ
Sponsors and contacts
Click on the lead sponsor to view all of their trials.